1. Hage K, Carson J, Hosseini-Hooshyar S, Sacks-Davis R, et al.
   Behavioural trajectories following DAA treatment for HCV among people with HIV: findings from an international consortium of prospective cohort studies.
   AIDS 2025.
   


2. Babu AM, Janzen D, Evans CD, Spence C, et al.
   Antiretroviral utilization and adherence before versus after expansion of a provincial drug insurance policy.
   AIDS 2025.
   


3. Veloso M, Ribeiro M, Cabanas J, Goncalves F, et al.
   Emerging patterns in HIV integrase resistance.
   AIDS 2025;39:2324-2327.
   


4. de Armas LR, Tuyishime M, Justement JS, Jha S, et al.
   Resistance to broadly neutralizing antibodies in perinatally infected infants from a Clade C HIV cohort in Mozambique.
   AIDS 2025;39:2321-2324.
   


5. Nghiem VTH, Braithwaite RS.
   COVID-19 as a natural experiment intervention to reduce new HIV infections among Australian MSM.
   AIDS 2025;39:2319-2320.
   


6. Jeena L, Kahari C, Ward KA, Gregson CL, et al.
   The effects of HIV on bone and muscle health through the lifespan in populations living in Africa.
   AIDS 2025;39:2161-2175.
   


7. Dhanjal A, Shaw JG, Cole J, Green LR, et al.
   Intersecting infections: the enhancing effect of Neisseria gonorrhoeae pathogenesis on HIV-1.
   AIDS 2025;39:2151-2160.
   


8. Brummel SS, Swanson S, Caniglia E, Lockman S, et al.
   A lesson in embracing uncertainty in early safety signals from the Tsepamo study.
   AIDS 2025;39:2266-2273.
   


9. Bachelard A, Julia Z, Damond F, Barral T, et al.
   Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1-Infected Pregnant Women: Real-Life Use.
   AIDS Res Hum Retroviruses 2025.
   


10. Kwaghe VG, Erameh C, Vongdip NG, Edeawe OI, et al.
    Fulminant Yersinia Pestis Infection in a Known HIV-Positive Patient: A Case Report of Identification in Nigeria 2024.
    Clin Infect Dis 2025;81:S186-S189.
    


11. Olcott F, Oddie PD, Barlow MJ, Mamarelis A, et al.
    Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practice.
    Clin Infect Dis 2025.
    


12. van Santen DK, Chalouni M, Berenguer J, Jarrin I, et al.
    Risk of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C virus infection in people with HIV.
    Clin Infect Dis 2025.
    


13. Murrill MT, Velasquez GE, Szumowski JD, Phillips A, et al.
    Tuberculosis infection screening recommendations for targeted immunotherapies: comparison of U.S. prescribing information, clinical resources and quality measures.
    Clin Infect Dis 2025.
    


14. Martinez-Sanz J, Garcia-Ruiz de Morales AG, Macias J, Rivero A, et al.
    Trends in Age-Related Health Outcomes in People with HIV in Spain, 2006-2023.
    Clin Infect Dis 2025.
    


15. Zuger A.
    Home testing for contagious illness: Historical context and modern caveats.
    Clin Infect Dis 2025.
    


16. Mauermann ML, Staff NP.
    Peripheral Neuropathy: A Review.
    JAMA 2025.
    


17. Serghides L, Lee J, Jacobson DL, Geffner ME, et al.
    Is gestational exposure to HIV and protease inhibitors associated with timing of pubertal onset?
    J Acquir Immune Defic Syndr 2025.
    


18. Nalugga EA, Musaazi J, Manabe YC, Kalema N, et al.
    Adverse drug reactions related to isoniazid preventive therapy among persons living with HIV on dolutegravir-based regimens in Uganda between July 2019 and March 2020.
    J Acquir Immune Defic Syndr 2025.
    


19. Onoya D, Shumba K, Mudara C, Nattey C, et al.
    Timing of ART initiation with treatment policy changes in South Africa: a cohort study.
    J Acquir Immune Defic Syndr 2025.
    


20. Bassett IV, Yan J, Govere S, Johnson LS, et al.
    PrEP and contraceptive persistence among young women receiving sexual and reproductive health services through hair salons in South Africa.
    J Acquir Immune Defic Syndr 2025.
    


21. Alvarez JA, Teeny S, Yang CA, Mehta CC, et al.
    Altered lipid and neurotransmitter metabolism as potential mechanisms of weight gain in women with HIV initiating INSTIs in a pilot study.
    J Acquir Immune Defic Syndr 2025.
    


22. Graybill LA, Huffstetler HE, Mtande TK, Krysiak R, et al.
    Identifying pregnant women at high risk of HIV acquisition: An external validation assessment of an HIV risk assessment tool for pregnant women.
    J Acquir Immune Defic Syndr 2025.
    


23. Stenlander C, Lindahl H, Wahren-Borgstrom E, Geier CB, et al.
    Bronchiectasis, Low IgG Levels and Lack of Vaccination are Risk Factors for Covid-19 Hospitalization in X-linked Agammaglobulinemia - A Retrospective Multicenter Study.
    J Clin Immunol 2025;45:161.
    


24. Zhang J, Wang Y, Chen L, Feng P, et al.
    Efficacy and Safety of Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori Infection Among People Living With HIV.
    J Infect Dis 2025;232:S367-S374.
    


25. Chan P, Sacdalan C, Pinyakorn S, Kroon E, et al.
    Neuroaxonal Injury in Acute HIV Infection and Following Immediate Antiretroviral Therapy.
    J Infect Dis 2025.
    


26. Weiser J.
    With All Good Intentions: How CDC Decisions Harmed Science and People.
    J Infect Dis 2025.
    


27. Gianella S, Taylor J, Shelton B, MacLean F, et al.
    In Response to Schmitt et al: Data Do Not Support Exclusionary Policies.
    J Infect Dis 2025.
    


28. Fazli P, Bakhtiari S, Jalilian FA, Teimoori A, et al.
    Clinical and Immunological Impact of Occult Hepatitis B Virus Infection Among HIV-Infected Patients With and Without HCV Co-Infection in Iran: A Cross-Sectional Analysis.
    J Med Virol 2025;97:e70715.
    


29. Adachi E, Okuno S, Kanno Y, Koga M, et al.
    Contemporary Antiretroviral Therapy Regimens in People With HIV Who Initiated Treatment in the Pre-Antiretroviral Therapy Era.
    J Med Virol 2025;97:e70708.
    


30. Zurowska K, Dzhivhuho G, Grabski D, Rekosh D, et al.
    Characterization of HERV-K (HML-2) Rec proteins encoded in the human genome and their post-transcriptional function.
    J Virol 2025.
    


31. Shuter J, Goel S, Himelhoch SS.
    Integration of Tobacco-Cessation Interventions into Tuberculosis and HIV Care.
    N Engl J Med 2025;393:1969-1972.
    

Display articles in

• Abstract format